{"entity":{"type":"insider","cik":"0001548144","url":"/insider/0001548144","json_url":"/insider/0001548144.json","name":"GOEL DAVID E.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":26,"n_filings":10,"first":"2014-01-30","last":"2026-05-11","span_basis":"filed_date"},"name_variants":[{"name":"GOEL DAVID E.","source":"filing","n_filings":10,"first_seen":"2014-01-30","last_seen":"2026-05-11"}],"transactions":[{"id":5927593,"accession":"0000950142-26-001346","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950142-26-001346","line_url":"/filing/0000950142-26-001346#line-1","is_derivative":false,"issuer_cik":"0001410830","issuer_name":"Aura Biosciences, Inc.","issuer_ticker":"AURA","issuer_name_source":null,"issuer_url":"/issuer/0001410830","owner_cik":null,"owner_name":"GOEL DAVID E.; Matrix Capital Management Company, LP","owner_display_name":"GOEL DAVID E.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, par value $0.00001 per share (Common Stock)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6922870.0,"shares_display":"6,922,870","price_per_share":5.64,"price_display":"5.64","price_state":"stated","total_value":39044986.8,"total_display":"39,044,986.80","total_whole":"39,044,987","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-07","filed_date":"2026-05-11","scope":"insider"},{"id":4369637,"accession":"0000902664-25-005288","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-25-005288","line_url":"/filing/0000902664-25-005288#line-1","is_derivative":false,"issuer_cik":"0001410830","issuer_name":"Zentalis Pharmaceuticals, Inc.","issuer_ticker":"ZNTL","issuer_name_source":null,"issuer_url":"/issuer/0001410830","owner_cik":null,"owner_name":"GOEL DAVID E.; Matrix Capital Management Company, LP","owner_display_name":"GOEL DAVID E.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500000.0,"shares_display":"7,500,000","price_per_share":1.33,"price_display":"1.33","price_state":"stated","total_value":9975000.0,"total_display":"9,975,000.00","total_whole":"9,975,000","shares_owned_after":6459973.0,"shares_owned_after_display":"6,459,973","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-15","filed_date":"2025-12-15","scope":"insider"},{"id":7800084,"accession":"0000902664-23-005429","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-23-005429","line_url":"/filing/0000902664-23-005429#line-1","is_derivative":false,"issuer_cik":"0001410830","issuer_name":"Aura Biosciences, Inc.","issuer_ticker":"AURA","issuer_name_source":null,"issuer_url":"/issuer/0001410830","owner_cik":null,"owner_name":"Matrix Capital Management Company, LP; GOEL DAVID E.","owner_display_name":"Matrix Capital Management Company, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, par value $0.00001 per share (Common Stock)","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1560000.0,"shares_display":"1,560,000","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":14040000.0,"total_display":"14,040,000.00","total_whole":"14,040,000","shares_owned_after":6922870.0,"shares_owned_after_display":"6,922,870","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-09","filed_date":"2023-11-09","scope":"insider"},{"id":7939493,"accession":"0000902664-23-003642","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-23-003642","line_url":"/filing/0000902664-23-003642#line-1","is_derivative":false,"issuer_cik":"0001410830","issuer_name":"Zentalis Pharmaceuticals, Inc.","issuer_ticker":"ZNTL","issuer_name_source":null,"issuer_url":"/issuer/0001410830","owner_cik":null,"owner_name":"Matrix Capital Management Company, LP; GOEL DAVID E.","owner_display_name":"Matrix Capital Management Company, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4760000.0,"shares_display":"4,760,000","price_per_share":22.66,"price_display":"22.66","price_state":"stated","total_value":107861600.0,"total_display":"107,861,600.00","total_whole":"107,861,600","shares_owned_after":13959973.0,"shares_owned_after_display":"13,959,973","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-20","filed_date":"2023-06-20","scope":"insider"},{"id":6842049,"accession":"0000902664-22-005061","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-22-005061","line_url":"/filing/0000902664-22-005061#line-1","is_derivative":false,"issuer_cik":"0001410830","issuer_name":"Aura Biosciences, Inc.","issuer_ticker":"AURA","issuer_name_source":null,"issuer_url":"/issuer/0001410830","owner_cik":null,"owner_name":"GOEL DAVID E.; Matrix Capital Management Company, LP","owner_display_name":"GOEL DAVID E.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, par value $0.00001 per share (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1250000.0,"shares_display":"1,250,000","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":15000000.0,"total_display":"15,000,000.00","total_whole":"15,000,000","shares_owned_after":5362870.0,"shares_owned_after_display":"5,362,870","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-05","filed_date":"2022-12-07","scope":"insider"},{"id":4663310,"accession":"0000902664-21-004738","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-21-004738","line_url":"/filing/0000902664-21-004738#line-1","is_derivative":false,"issuer_cik":"0001410830","issuer_name":"Aura Biosciences, Inc.","issuer_ticker":"AURA","issuer_name_source":null,"issuer_url":"/issuer/0001410830","owner_cik":null,"owner_name":"GOEL DAVID E.; Matrix Capital Management Company, LP","owner_display_name":"GOEL DAVID E.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1785000.0,"shares_display":"1,785,000","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":24990000.0,"total_display":"24,990,000.00","total_whole":"24,990,000","shares_owned_after":4112870.0,"shares_owned_after_display":"4,112,870","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-02","filed_date":"2021-11-04","scope":"insider"},{"id":4510338,"accession":"0000902664-21-001835","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000902664-21-001835","line_url":"/filing/0000902664-21-001835","is_derivative":false,"issuer_cik":"0001410830","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001410830","owner_cik":null,"owner_name":"Matrix Capital Management Company, LP; GOEL DAVID E.","owner_display_name":"Matrix Capital Management Company, LP","owner_url":null,"role":"Director, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":56000.0,"shares_display":"56,000","price_per_share":41.9589388,"price_display":"41.96","price_state":"stated","total_value":2349700.5728,"total_display":"2,349,700.57","total_whole":"2,349,701","shares_owned_after":12309090.0,"shares_owned_after_display":"12,309,090","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-10","filed_date":"2021-03-10","scope":"insider","n_lines":2},{"id":4510331,"accession":"0000902664-21-001835","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000902664-21-001835","line_url":"/filing/0000902664-21-001835","is_derivative":false,"issuer_cik":"0001410830","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001410830","owner_cik":null,"owner_name":"Matrix Capital Management Company, LP; GOEL DAVID E.","owner_display_name":"Matrix Capital Management Company, LP","owner_url":null,"role":"Director, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250000.0,"shares_display":"250,000","price_per_share":40.5248811336,"price_display":"40.52","price_state":"stated","total_value":10131220.2834,"total_display":"10,131,220.28","total_whole":"10,131,220","shares_owned_after":12399392.0,"shares_owned_after_display":"12,399,392","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-09","filed_date":"2021-03-10","scope":"insider","n_lines":2},{"id":4510324,"accession":"0000902664-21-001835","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000902664-21-001835","line_url":"/filing/0000902664-21-001835","is_derivative":false,"issuer_cik":"0001410830","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001410830","owner_cik":null,"owner_name":"Matrix Capital Management Company, LP; GOEL DAVID E.","owner_display_name":"Matrix Capital Management Company, LP","owner_url":null,"role":"Director, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500000.0,"shares_display":"500,000","price_per_share":39.4958117586,"price_display":"39.50","price_state":"stated","total_value":19747905.8793,"total_display":"19,747,905.88","total_whole":"19,747,906","shares_owned_after":12880795.0,"shares_owned_after_display":"12,880,795","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-08","filed_date":"2021-03-10","scope":"insider","n_lines":5},{"id":2170014,"accession":"0000902664-20-002761","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-20-002761","line_url":"/filing/0000902664-20-002761#line-1","is_derivative":false,"issuer_cik":"0001410830","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001410830","owner_cik":null,"owner_name":"GOEL DAVID E.; Matrix Capital Management Company, LP","owner_display_name":"GOEL DAVID E.","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000000.0,"shares_display":"2,000,000","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":80000000.0,"total_display":"80,000,000.00","total_whole":"80,000,000","shares_owned_after":13115090.0,"shares_owned_after_display":"13,115,090","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-20","filed_date":"2020-07-22","scope":"insider"},{"id":6383123,"accession":"0001209191-14-034648","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-034648","line_url":"/filing/0001209191-14-034648","is_derivative":false,"issuer_cik":"0000763901","issuer_name":"POPULAR INC","issuer_ticker":"BPOP","issuer_name_source":null,"issuer_url":"/issuer/0000763901","owner_cik":"0001548144","owner_name":"GOEL DAVID E.","owner_display_name":"GOEL DAVID E.","owner_url":"/insider/0001548144","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock Par Value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250000.0,"shares_display":"250,000","price_per_share":28.53,"price_display":"28.53","price_state":"stated","total_value":7132500.0,"total_display":"7,132,500.00","total_whole":"7,132,500","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-05-15","filed_date":"2014-05-16","scope":"insider","n_lines":2},{"id":6383117,"accession":"0001209191-14-034648","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-034648","line_url":"/filing/0001209191-14-034648","is_derivative":false,"issuer_cik":"0000763901","issuer_name":"POPULAR INC","issuer_ticker":"BPOP","issuer_name_source":null,"issuer_url":"/issuer/0000763901","owner_cik":"0001548144","owner_name":"GOEL DAVID E.","owner_display_name":"GOEL DAVID E.","owner_url":"/insider/0001548144","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock Par Value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":216176.0,"shares_display":"216,176","price_per_share":29.29,"price_display":"29.29","price_state":"stated","total_value":6331795.04,"total_display":"6,331,795.04","total_whole":"6,331,795","shares_owned_after":245784.0,"shares_owned_after_display":"245,784","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-05-14","filed_date":"2014-05-16","scope":"insider","n_lines":2},{"id":6186824,"accession":"0001209191-14-006001","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-14-006001","line_url":"/filing/0001209191-14-006001","is_derivative":false,"issuer_cik":"0000763901","issuer_name":"POPULAR INC","issuer_ticker":"BPOP","issuer_name_source":null,"issuer_url":"/issuer/0000763901","owner_cik":"0001548144","owner_name":"GOEL DAVID E.","owner_display_name":"GOEL DAVID E.","owner_url":"/insider/0001548144","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock Par Value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300000.0,"shares_display":"300,000","price_per_share":26.6,"price_display":"26.60","price_state":"stated","total_value":7980000.0,"total_display":"7,980,000.00","total_whole":"7,980,000","shares_owned_after":457270.0,"shares_owned_after_display":"457,270","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-01-30","filed_date":"2014-01-30","scope":"insider","n_lines":2},{"id":6186815,"accession":"0001209191-14-006001","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-006001","line_url":"/filing/0001209191-14-006001","is_derivative":false,"issuer_cik":"0000763901","issuer_name":"POPULAR INC","issuer_ticker":"BPOP","issuer_name_source":null,"issuer_url":"/issuer/0000763901","owner_cik":"0001548144","owner_name":"GOEL DAVID E.","owner_display_name":"GOEL DAVID E.","owner_url":"/insider/0001548144","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock Par Value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300000.0,"shares_display":"300,000","price_per_share":27.74,"price_display":"27.74","price_state":"stated","total_value":8322000.0,"total_display":"8,322,000.00","total_whole":"8,322,000","shares_owned_after":751539.0,"shares_owned_after_display":"751,539","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-01-29","filed_date":"2014-01-30","scope":"insider","n_lines":2},{"id":6186807,"accession":"0001209191-14-006001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-006001","line_url":"/filing/0001209191-14-006001","is_derivative":false,"issuer_cik":"0000763901","issuer_name":"POPULAR INC","issuer_ticker":"BPOP","issuer_name_source":null,"issuer_url":"/issuer/0000763901","owner_cik":"0001548144","owner_name":"GOEL DAVID E.","owner_display_name":"GOEL DAVID E.","owner_url":"/insider/0001548144","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock Par Value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400000.0,"shares_display":"400,000","price_per_share":28.34,"price_display":"28.34","price_state":"stated","total_value":11336000.0,"total_display":"11,336,000.00","total_whole":"11,336,000","shares_owned_after":1045808.0,"shares_owned_after_display":"1,045,808","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-01-28","filed_date":"2014-01-30","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001501796","name":"Aura Biosciences, Inc.","url":"/issuer/0001501796","role":"Ten percent owner","n_filings":4,"first_seen":"2021-11-04","last_seen":"2026-05-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001725160","name":"Zentalis Pharmaceuticals, Inc.","url":"/issuer/0001725160","role":"Ten percent owner","n_filings":2,"first_seen":"2023-06-20","last_seen":"2025-12-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001478320","name":"Adaptive Biotechnologies Corp","url":"/issuer/0001478320","role":"Director, Ten percent owner, Other","n_filings":2,"first_seen":"2020-07-22","last_seen":"2021-03-10"},{"type":"issuer","type_label":"ISSUER","cik":"0000763901","name":"POPULAR INC","url":"/issuer/0000763901","role":"Director","n_filings":2,"first_seen":"2014-01-30","last_seen":"2014-05-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001548144","retrieved_at":"2026-08-25T20:34:18+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}